Open an Account
search icon
4
NOTIFICATIONS
Best Algo trading app in India
Bigul

Alkem Laboratories Ltd - 539523 - Board Meeting Intimation for Notice Of Board Meeting Of Directors Of Alkem Laboratories Limited

 Alkem Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 09/02/2024 ,inter alia, to consider and approve (i) the Standalone and Consolidated Unaudited Financial Results of the Company for the quarter and nine months ended 31st December, 2023; and (ii) Interim Dividend for financial year 2023-2024. The record date for the purpose of payment of Interim Dividend for financial year 2023-2024, would be Saturday, 17th February, 2024, subject to declaration of the said Interim Dividend by the Board of Directors in its meeting to be held on 09th February, 2024.
01-02-2024
Bigul

Alkem Laboratories Ltd - 539523 - Intimation Of Request Received For Reclassification By Members Of Promoter Group Under Regulation 31A Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015.

 We wish to inform you that the Company is in receipt of request under Regulation 31A of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 from certain members of Promoter Group seeking reclassification from ''Promoter Group'' to ''Public'' category. Kindly take the same on record.
30-01-2024
Bigul

Alkem Laboratories Ltd - 539523 - General- Intimation Under Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations, 2015 With Respect To A Cyber Security Incident

 Details with respect to the captioned subject has been enclosed herewith. kindly take the same on records.
12-01-2024
Bigul

Alkem Laboratories Ltd - 539523 - Announcement under Regulation 30 (LODR)-Change in Management

 We wish to inform you that the Company has appointed Mr. Nitin Agrawal as Chief Financial Officer of the Company with effect from 01st February, 2024. Kindly take the same on record.
12-01-2024
Bigul

Alkem Laboratories Ltd - 539523 - Shareholder Meeting / Postal Ballot-Scrutinizer"s Report

 Please find enclosed herewith the details regarding the voting results of the business transacted through Postal Ballot by remote e-voting process in the prescribed format alongwith the Scrutinizer''s Report.
08-01-2024
Bigul

Alkem Laboratories Ltd - 539523 - Shareholder Meeting / Postal Ballot-Outcome of Postal Ballot

 Please find attached herewith the details regarding the voting results of the business transacted through Postal Ballot by remote e-voting process in the prescribed format along with the Scrutinizers Report.
08-01-2024

Alkem Labs hits 52-week high on sell of US facility to New Mill Capital Holdings

 The company received total consideration of USD 7,960,000.
01-01-2024
Bigul

Alkem Laboratories Ltd - 539523 - Announcement Under Regulation 30 (LODR)- Sale Of St. Louis Manufacturing Facility Of The Company Situated In USA

 As part of the Company''s operational strategy, the operations of the Company carried out at St. Louis manufacturing facility situated in USA owned by M/s. S&B Pharma LLC, a step-down subsidiary of the Company ("Facility") are closed. Accordingly, all rights, title and interest in the said land, improvements and personal property with respect to the said Facility owned by M/s S&B Pharma LLC, a step-down subsidiary of the Company in USA ("Seller") are sold to M/s. New Mill Capital Holdings LLC ("Buyer") pursuant to the ''Purchase and Sale Agreement'' executed between the Buyer and Seller. The required details are enclosed as Annexure I.
30-12-2023
Bigul

Alkem Laboratories Ltd - 539523 - Closure of Trading Window

 This is to inform you that in terms of Company''s Code of Conduct for Regulating, Monitoring and Reporting of Trading by Insiders, the trading window shall remain closed from 30th December, 2023 until the expiry of 48 hours after the date on which the financial results of the Company for the quarter and nine months ended 31st December, 2023 are communicated to the Stock Exchanges.
21-12-2023
Bigul

Alkem Laboratories Ltd - 539523 - Announcement under Regulation 30 (LODR)-Change in Management

 Pursuant to Regulation 30 of SEBI Listing Regulations, we wish to inform you about the change in senior management personnel of the Company.
15-12-2023
Next Page
Close

Let's Open Free Demat Account